Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers

Cytotoxic T lymphocyte (CTL)-based cancer immunotherapies have shown great promise for inducing clinical regressions by targeting tumor-associated antigens (TAA). To expand the TAA landscape of pancreatic ductal adenocarcinoma (PDAC), we performed tandem mass spectrometry analysis of HLA class I-bou...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradley, Sherille D., Talukder, Amjad H., Lai, Ivy, Davis, Rebecca, Alvarez, Hector, Tiriac, Herve, Zhang, Minying, Chiu, Yulun, Melendez, Brenda, Jackson, Kyle R., Katailiha, Arjun, Sonnemann, Heather M., Li, Fenge, Kang, Yaan, Qiao, Na, Pan, Bih-Fang, Lorenzi, Philip L., Hurd, Mark, Mittendorf, Elizabeth A., Peterson, Christine B., Javle, Milind, Bristow, Christopher, Kim, Michael, Tuveson, David A., Hawke, David, Kopetz, Scott, Wolff, Robert A., Hwu, Patrick, Maitra, Anirban, Roszik, Jason, Yee, Cassian, Lizée, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577998/
https://www.ncbi.nlm.nih.gov/pubmed/33087697
http://dx.doi.org/10.1038/s41467-020-19141-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577998/
https://www.ncbi.nlm.nih.gov/pubmed/33087697
http://dx.doi.org/10.1038/s41467-020-19141-w

Ejemplares similares